Method for the alteration of plants using CLE polypeptides/peptides

US10023878B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10023878-B2
Application numberUS-201414253428-A
CountryUS
Kind codeB2
Filing dateApr 15, 2014
Priority dateSep 9, 2008
Publication dateJul 17, 2018
Grant dateJul 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to altering the biomass and/or structure of a plant, in order to maximize its potential as a source of feedstock or increase its potential as a feedstock for the paper industry. CLE41 and/or CLE42 are used to manipulate growth and structure of the vascular tissue of the plant. The present invention also provides plants in which the levels of CLE41 and/or CLE42 are increased compared to those of a native plant grown under identical conditions, and parts of such plants. Also provided are methods for using such plants or plant parts in the production of plant derived products such as paper or biofuels.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of manipulating the growth and/or structure of a plant, the method comprising modulating the level of Clavata3/Endosperm Surrounding Region (ESR)-related 41 (CLE41) in the plant, wherein the levels of CLE 41 are modulated by introducing into a cell of the plant: I) a recombinant genetic construct comprising a nucleic acid molecule selected from the group consisting of: i) a nucleic acid molecule that encodes a polypeptide comprising the amino acid sequence of amino acids 124 to 137 of the consensus sequence of SEQ ID NO:12 and a hydrophobic region at the amino terminus, and the nucleic acid molecule has at least 90% sequence identity to the nucleotide sequence of CLE 41 of SEQ ID NO:22, and; ii) a nucleic acid molecule that hybridizes under stringent conditions of hybridization in 6× sodium chloride/sodium citrate at about 45° C. followed by one or more washes in 0.2×SSC 0.2% (w/v) SDS at 50° C. to the nucleotide sequence of Ii; in combination with II) a recombinant genetic construct comprising a nucleic acid molecule selected from the group consisting of: i) a nucleic acid molecule that encodes a polypeptide comprising the consensus sequence of SEQ ID NO:20 and having at least 90% sequence identity to the nucleotide sequence of SEQ ID NO: 26 or SEQ ID NO: 27, and ii) a nucleic acid molecule that hybridizes under stringent conditions of hybridization in 6× sodium chloride/sodium citrate at about 45° C. followed by one or more washes in 0.2×SSC 0.2% (w/v) SDS at 50° C. to the nucleotide sequence IIi), and thereby manipulating the growth and/or structure of the plant. 2. The method according to claim 1 , wherein the levels of CLE41 are upregulated. 3. A method of manipulating the growth and/or structure of a plant, the method comprising the steps of: i) providing a cell manipulated to express: 1) a CLE41 polypeptide, in combination with a recombinant genetic construct according to claim 1 (II); 2) a polypeptide selected from the group consisting of: a) a polypeptide comprising amino acids 124 to 137 of the consensus sequence of SEQ ID NO:12, a hydrophobic region at the amino terminus, and having at least 90% sequence identity to the amino acid sequence of CLE 41 of SEQ ID NO: 21, and b) a polypeptide comprising the consensus sequence of SEQ ID NO:12, a hydrophobic region at the amino terminus, and encoded by a nucleic acid molecule having at least 90% sequence identity to the nucleotide sequence of CLE 41 of SEQ ID NO:22, in combination with a recombinant genetic construct according to claim 1 (II); or 3) a recombinant genetic construct according to claim 1 (I) in combination with a recombinant genetic construct according to claim 1 (II) or a polypeptide according selected from the group consisting of: a) a polypeptide comprising the consensus sequence of SEQ ID NO:20 and having at least 90% sequence identity to the Phloem Intercalating with Xylem (PXY) sequence of SEQ ID NO:25, and b) a polypeptide comprising the consensus sequence of SEQ ID NO:20 and encoded by a nucleic acid molecule that is at least 90% identical to the PXY nucleotide sequence of SEQ ID NO:26 or SEQ ID NO:27; ii) regenerating said cell into a plant; and optionally iii) monitoring the levels of CLE41 or a receptor thereof, and/or PXY in said regenerated plant, and thereby manipulating the growth and/or structure of the plant. 4. A method of producing a plant-derived product, the method comprising: i) manipulating the growth and/or structure of a plant produced according to claim 1 ; ii) growing the plant until it reaches a pre-determined lateral size; and optionally iii) harvesting the plant-derived product produced by the plant. 5. A method of altering the mechanical properties of a plant or plant derived product, the method comprising: i) manipulating the growth and/or structure of a plant according to claim 1 ; ii) growing the plant until it reaches a pre-determined size; and optionally iii) harvesting a plant-derived product wherein the mechanical properties of the plant or the plant-derived product are altered.

Assignees

Inventors

Classifications

  • Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

  • with agronomic (input) traits, e.g. crop yield · CPC title

  • Hormone-influenced development · CPC title

  • N-acyl derivatives · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10023878B2 cover?
The present invention relates to altering the biomass and/or structure of a plant, in order to maximize its potential as a source of feedstock or increase its potential as a feedstock for the paper industry. CLE41 and/or CLE42 are used to manipulate growth and structure of the vascular tissue of the plant. The present invention also provides plants in which the levels of CLE41 and/or CLE42 are …
Who is the assignee on this patent?
Plant Bioscience Ltd, Stora Enso Oyj
What technology area does this patent fall under?
Primary CPC classification C12N15/8261. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).